A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
Clinical trial NCT04053881 · COMPLETED
Trial details
- NCT number
- NCT04053881
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-21
- Primary completion
- 2022-12-02
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.